Ra Capital Management, L.P. Fulcrum Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
A detailed history of Ra Capital Management, L.P. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 11,609,704 shares of FULC stock, worth $36.9 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
11,609,704Holding current value
$36.9 Million% of portfolio
1.08%Shares
5 transactions
Others Institutions Holding FULC
# of Institutions
135Shares Held
59.5MCall Options Held
4.32MPut Options Held
307K-
Rtw Investments, LP New York, NY5.85MShares$18.6 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$15.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$9.77 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$9.43 Million0.47% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.54MShares$8.08 Million0.66% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $165M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...